Abstract
This study evaluated the effectiveness and safety of intensity-modulated radiation therapy (IMRT) for locally advanced esophageal squamous cell carcinoma (ESCC). Between August 2009 and December 2011, 112 patients with pathologically confirmed ESCC treated with IMRT at Jiangsu Province People's Hospital and Nantong Tumor Hospital were included in a retrospective analysis. Patients received either IMRT alone (group A) or concurrent chemoradiotherapy (CRT) (group B). A radiation dose of 60-66 Gy administered in 30-33 fractions was delivered to the tumor. The patients in group B simultaneously received 2 cycles of cisplatin-based doublets with either 5-fluorouracil or taxotere. The Kaplan-Meier method was used to compute the survival time. Early and late toxicities were scored according to CTCAE v.3.0. The response rate of group B (91.07%) was not significantly greater than that of group A (89.29%) (χ2 = 0.10, p = 0.75). The 1- and 3-year survival rates of group B (87.5% and 57.14%, respectively) were greater than those of group A (69.64% and 37.50%, respectively). The difference in overall survival was statistically significant between groups A and B (χ2 = 5.30, p = 0.02; χ2 = 4.33, p = 0.04). Hematological toxicity, gastrointest...Continue Reading
References
Jun 11, 1992·The New England Journal of Medicine·A HerskovicB Emami
Jun 1, 1980·The British Journal of Surgery·R Earlam, J R Cunha-Melo
Jul 8, 2000·The British Journal of Radiology·C NuttingS Webb
Oct 17, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D M ParkinS S Devesa
Nov 3, 2001·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·C M NuttingS Webb
Mar 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D MinskyDavid P Kelsen
Jul 16, 2002·Seminars in Radiation Oncology·Michael J ZelefskySteven A Leibel
Aug 10, 2002·Annals of Surgery·Nasser AltorkiJeffrey Port
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Satoshi IshikuraShigeaki Yoshida
Dec 6, 2003·The New England Journal of Medicine·Peter C Enzinger, Robert J Mayer
Feb 15, 2005·International Journal of Radiation Oncology, Biology, Physics·Zhen ZhangRitsuko Komaki
Mar 25, 2005·Acta Oncologica·Dirk NeuhofFrederik Wenz
Feb 22, 2008·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Dec 3, 2011·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·R SemrauR-P Müller
May 3, 2012·The Oncologist·Gregory VlacichAnthony J Cmelak
Oct 30, 2012·Journal of Gastrointestinal Cancer·Y RostomD Abd-Allah
Mar 28, 2013·Radiation Oncology·Lingli TuYouling Gong
Mar 29, 2014·Radiation Oncology·Jia-Xin LiTai-xiang Lu
Mar 29, 2014·Tumori·Ludovica PegurriStefano Maria Magrini
May 29, 2014·International Journal of Radiation Oncology, Biology, Physics·Katsuhiko HiguchiUNKNOWN Kitasato Digestive Disease and Oncology Group
Citations
May 16, 2017·Expert Review of Anticancer Therapy·Mian Xi, Steven H Lin
Apr 21, 2020·Journal of Oncology·Xing-Hua BaiGuang Li
Jan 14, 2021·Radiation Oncology·Chengbing ZengChuangzhen Chen